Core Laboratories N.V. (CLB) Revenue History
Annual and quarterly revenue from 1995 to present
CLB Revenue Over Time (1995–2025)
CLB Revenue Growth History
23 of 30 years with positive growth- FY1995 revenue growth
- N/A
- FY1996 revenue growth
- +31.6%
- FY1997 revenue growth
- +103.9%
- FY1998 revenue growth
- +33.2%
- FY1999 revenue growth
- +6.1%
- FY2000 revenue growth
- +10.7%
- FY2001 revenue growth
- +12.0%
- FY2002 revenue growth
- -3.1%
- FY2003 revenue growth
- +11.2%
- FY2004 revenue growth
- +5.4%
- FY2005 revenue growth
- +13.1%
- FY2006 revenue growth
- +19.1%
- FY2007 revenue growth
- +16.5%
- FY2008 revenue growth
- +16.4%
- FY2009 revenue growth
- -10.9%
- FY2010 revenue growth
- +14.2%
- FY2011 revenue growth
- +14.2%
- FY2012 revenue growth
- +8.1%
- FY2013 revenue growth
- +9.4%
- FY2014 revenue growth
- +1.1%
- FY2015 revenue growth
- -26.5%
- FY2016 revenue growth
- -25.4%
- FY2017 revenue growth
- +10.9%
- FY2018 revenue growth
- +6.2%
- FY2019 revenue growth
- -4.7%
- FY2020 revenue growth
- -27.1%
- FY2021 revenue growth
- -3.5%
- FY2022 revenue growth
- +4.1%
- FY2023 revenue growth
- +4.1%
- FY2024 revenue growth
- +2.8%
- FY2025 revenue growth
- +0.5%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $121.8M | -1.4% |
| Q4 2025 | $138.3M | +7.0% |
| Q3 2025 | $134.5M | +0.1% |
| Q2 2025 | $130.2M | -0.3% |
| Q1 2025 | $123.6M | -4.7% |
| Q4 2024 | $129.2M | +0.8% |
| Q3 2024 | $134.4M | +7.2% |
| Q2 2024 | $130.6M | +2.1% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
CLB's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
CLB Revenue Analysis (1995–2025)
Current Revenue & Growth
As of June 16, 2026, Core Laboratories N.V. (CLB) generated trailing twelve-month (TTM) revenue of $524.7 million, reflecting slight decline in growth of -1.4% year-over-year. The most recent quarter (Q1 2026) recorded $121.8 million in revenue, down 11.9% sequentially.
Historical Growth Trajectory
CLB's 5-year compound annual growth rate (CAGR) stands at +1.6%, indicating moderate growth over time. The 3-year CAGR of +2.4% exceeds the 5-year average, indicating an acceleration in the most recent period. Core Laboratories N.V.'s highest annual revenue of $1.09 billion was recorded in 2014.
Revenue by Segment
CLB's revenue is primarily driven by Service (76%), and Product (24%). With over half of revenue concentrated in Service, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Energy sector peers — including LBRT (-4.0% YoY), NINE (-3.7% YoY), and PUMP (-15.6% YoY) — CLB has underperformed the peer group in revenue growth. Compare CLB vs LBRT →
CLB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 CLBCurrent | $525M | -1.4% | +1.6% | 9.3% | |
 LBRT | $4.0B | -4.0% | +32.9% | 2.0% | |
 NINE | $562M | -3.7% | +12.6% | 0.1% | |
 PUMP | $1.3B | -15.6% | +10.0% | 1.5% | |
 PTEN | $4.8B | -9.4% | +33.8% | -0.5% | |
 RES | $1.6B | +27.6% | +22.1% | 3.5% |
CLB Historical Revenue Data (1995–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $526.5M | +0.5% | $94.3M | 17.9% | $48.9M | 9.3% |
| 2024 | $523.8M | +2.8% | $88.4M | 16.9% | $58.6M | 11.2% |
| 2023 | $509.8M | +4.1% | $94.0M | 18.4% | $54.6M | 10.7% |
| 2022 | $489.7M | +4.1% | $78.9M | 16.1% | $41.5M | 8.5% |
| 2021 | $470.3M | -3.5% | $83.8M | 17.8% | $45.3M | 9.6% |
| 2020 | $487.3M | -27.1% | $102.1M | 21.0% | $-76,805,000 | -15.8% |
| 2019 | $668.2M | -4.7% | $172.6M | 25.8% | $96.7M | 14.5% |
| 2018 | $700.8M | +6.2% | $180.8M | 25.8% | $118.6M | 16.9% |
| 2017 | $659.8M | +10.9% | $160.6M | 24.3% | $112.4M | 17.0% |
| 2016 | $594.7M | -25.4% | $125.2M | 21.1% | $86.2M | 14.5% |
| 2015 | $797.5M | -26.5% | $237.4M | 29.8% | $161.1M | 20.2% |
| 2014 | $1.09B | +1.1% | $393.3M | 36.2% | $346.5M | 31.9% |
| 2013 | $1.07B | +9.4% | $385.1M | 35.9% | $333.4M | 31.1% |
| 2012 | $981.1M | +8.1% | $336.3M | 34.3% | $297.3M | 30.3% |
| 2011 | $907.6M | +14.2% | $314.3M | 34.6% | $250.8M | 27.6% |
What if you invested $1,000 in CLB back in 1995?
Total return with dividends reinvested · 31+ years of data
Calculate ReturnsHow much would $100/month in CLB be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs CLB Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCLB vs XOM — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Exxon Mobil Corporation.
Compare NowCLB — Frequently Asked Questions
Quick answers to the most common questions about buying CLB stock.
Is CLB's revenue growth accelerating or slowing?
CLB revenue growth is slowing. TTM revenue is $525M, up -1.4% year-over-year — below the 5-year CAGR of +1.6%. The deceleration suggests maturing end-markets or increased competition.
What is CLB's revenue history from 1995 to 2026?
Core Laboratories N.V. (CLB) revenue history spans 1995 to 2026. TTM revenue as of 2026 is $525M, growing at -1.4% YoY. The 5-year CAGR is +1.6%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is CLB's long-term revenue growth rate (CAGR)?
Core Laboratories N.V.'s 5-year revenue CAGR of +1.6% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -1.4% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for CLB.
Why does CLB's quarterly revenue fluctuate?
CLB quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Core Laboratories N.V.'s revenue data from 1995 to 2026 shows full historical quarterly detail on this page.
How is CLB's revenue distributed by segment?
CLB reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does CLB's revenue compare to industry peers?
Core Laboratories N.V. (CLB) with TTM revenue of $525M and -1.4% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.